lymphoma: Indolent non-Hodgkin's lymphomas
In isglobal-brge/gcmrec: General class of models for recurrent event data
Description
Usage
Format
Source
Description
This contains cancer relapses times after first treatment in patients diagnosed with low grade lymphoma
Usage
1
Format
This data frame contains the following columns:
- id
identificator of each subject. Repeated for each recurrence
- time
interocurrence or censoring time
- event
censoring status. All event are 1 for each subject
excepting last one that it is 0
- enum
which lymphoma
- delay
delay between first symptom and date of first treatment as a
continuous variable
- age
age at diagnosis
- sex
gender: 1:Males 2:Females
- distrib
lesions involved at diagnosis (0=Single, 1=Localized, 2=More than
one nodal site, 3=Generalized
- effage
response achieved after treatment upon relapses, coded as CR: Complete remission,
PR: Partial remission or SD: stable disease or null response.
Source
JR Gonzalez, E Pe<c3><b1>a, E Slate (2005). Modelling treatment effect after cancer relapses, with application to
recurrences in indolent non-Hodgkin's lymphomas. Stat Med, submitted.
O. Servitje, F. Gallardo, T. Estrach, et al. (2002). Primary cutaneous marginal zone B-cell lymphoma: a clinical,
histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol,
147:1147-1158.
isglobal-brge/gcmrec documentation built on May 18, 2019, 5:50 a.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Description Usage Format Source
Description
This contains cancer relapses times after first treatment in patients diagnosed with low grade lymphoma
Usage
1 |
Format
This data frame contains the following columns:
- id
identificator of each subject. Repeated for each recurrence
- time
interocurrence or censoring time
- event
censoring status. All event are 1 for each subject excepting last one that it is 0
- enum
which lymphoma
- delay
delay between first symptom and date of first treatment as a continuous variable
- age
age at diagnosis
- sex
gender: 1:Males 2:Females
- distrib
lesions involved at diagnosis (0=Single, 1=Localized, 2=More than one nodal site, 3=Generalized
- effage
response achieved after treatment upon relapses, coded as CR: Complete remission, PR: Partial remission or SD: stable disease or null response.
Source
JR Gonzalez, E Pe<c3><b1>a, E Slate (2005). Modelling treatment effect after cancer relapses, with application to recurrences in indolent non-Hodgkin's lymphomas. Stat Med, submitted.
O. Servitje, F. Gallardo, T. Estrach, et al. (2002). Primary cutaneous marginal zone B-cell lymphoma: a clinical, histopathological, immunophenotypic and molecular genetic study of 22 cases. Br J Dermatol, 147:1147-1158.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.